Philips CPAP Recall Affects Millions of Consumers

By now, you may have heard the news that Philips Respironics is recalling millions of CPAP machines. Since the first announcement was made, the recall has made headlines numerous times. The CPAP recall includes 3-4 million machines that may be defective.

In July 2021, Drug and Device Watch posted information about the CPAP recall for our readers. The recall follows reports that the polyester-based polyurethane (PE-PUR) foam housed inside the machines can break down. Used to reduce sound and vibration, the foam could break down and leak chemicals into the air supply. Foam particles could also come loose, and potentially be inhaled.

The chemicals in the foam may also be carcinogenic, meaning that prolonged exposure could increase the risk of cancers, including kidney and liver cancers.

CPAP Recall Causes Ongoing Concerns

Since July, media outlets have reported on the concern and outrage of many consumers who are now facing a choice of using a potentially dangerous product, or suffering the consequences of not using a CPAP machine. For many consumers, stopping use could be fatal.

As of September 2021, Philips and the U.S. Food and Drug Administration (FDA) did not have suitable replacement recommendations. Healthcare providers now have to weigh the benefits and risks of using the CPAP machines, despite the recall.

For a full list of the CPAP machines in the recall, and for more information, take a look at the FDA Safety Communication.

Have Questions about a Recall?

If you or someone you love uses a Philips Respironics CPAP machine, you may have questions about the recall and what it all means. At National Injury Center, we want to help you find answers. Contact us to get in touch with a defective medical device lawyer. Our consultations are completely FREE, so you have nothing to lose. Complete our online form to get started.